Lincoln Pharmaceuticals Ltd has reported an increase of 4 per cent in revenue and 94 per cent in net profit in the third quarter of 2013-14 ended December 31, 2013, as compared to the corresponding quarter in the last fiscal.
While the company’s standalone revenue was Rs 51.98 crore (Rs 49.68 crore) and profit-after-tax (PAT) stood at Rs 3.83 crore (Rs 1.97 crore), according to a press release here.
The company increased profitability despite the pressure of inflation, increase in input cost and financial cost in general economic situation in the country.
Lincoln Pharma is considering new capital investments in the R&D unit and proposes to set up a USFDA rules compliant plant to cater to domestic as well as regulated markets.